Healthcare Costs: Employer Perspectives Shift from Alarm to Action

In the ever-evolving landscape of healthcare costs, the recent findings from the 2026 Pulse of the Purchaser survey, published by the National Alliance of Healthcare Purchaser Coalitions, reveal a significant shift in employer attitudes. While the apprehension surrounding specific healthcare cost threats, such as high drug prices and hospital expenses, has notably decreased, employers are increasingly vocal about their support for policy reforms. This dual trend of diminishing alarm coupled with rising advocacy for change presents a compelling narrative about how businesses are navigating the complex world of healthcare.

The survey, which gathered insights from 408 employers and purchasers between May and June 2026, highlights a self-selected group of industry players who are deeply engaged in healthcare procurement. The findings show that while concerns about affordability threats remain high, employers are feeling less overwhelmed by these challenges. Drug prices, high-cost claims, and hospital prices have consistently topped the list of affordability threats, but their perceived severity is waning, suggesting a potential normalization of expectations in the face of ongoing high costs.

Understanding the Decline in Threat Perception

The results from the survey indicate that the perceived threat of drug prices has decreased from 93.1% in 2024 to 76.7% in 2026. Similarly, concerns about hospital prices fell from 82.4% to 68.1%, and worries regarding health system consolidation dropped from 64.7% to 49.7%. This decline raises an important question: why are employers less alarmed about these persistent issues?

Possible Explanations for Decreased Alarm

• Genuine Improvement: It's possible that employers are becoming more adept at managing healthcare costs, leading to increased confidence in their strategies.
• Normalization: High costs may have become so commonplace that employers no longer perceive them as exceptional threats.
• Attention Shift: Employers may be redirecting their focus to other pressing issues, resulting in a reduced emphasis on previous cost concerns.

While the survey cannot definitively attribute these changes to any single cause, the prevailing interpretation suggests that employers may have reached a threshold of alarm, where the ongoing challenges of healthcare costs have become an accepted part of the landscape.

Rising Support for Policy Reform

The Impact of the 340B Drug Pricing Program

The concern among employers is twofold: while the program was designed to benefit low-income patients, it inadvertently leads to higher costs for employer-sponsored health plans. The absence of rebates on drugs dispensed under the 340B program can result in increased pharmacy costs, with estimates suggesting that the program dynamics added $5.2 billion to employer-sponsored plans in 2024 alone, equivalent to a 4.2% increase in costs.

Hospital-Specific Reforms and Employer Support

• Hospital Rate Regulation: Supported by 82.6% of employers, marking a 17-point increase from 2023.
• Hospital Antitrust Enforcement: Registered 72.2% support.
• Healthcare Global Budgets: Saw an increase in support to 45.6%, although it remains below majority levels.

Key Takeaways

• Employers are less alarmed about rising healthcare costs but support reforms to tackle them.
• Significant increases in support for PBM and drug price regulations indicate a push for accountability.
• The 340B Drug Pricing Program is a focal point for employers concerned about pharmacy costs.
• Support for hospital-specific reforms suggests a proactive stance among employers in healthcare policy.
• Engagement in legislative activities is growing, reflecting a shift towards active participation in healthcare reform.

Frequently Asked Questions

What is the Pulse of the Purchaser survey?

The Pulse of the Purchaser survey is conducted by the National Alliance of Healthcare Purchaser Coalitions and provides insights into employer attitudes towards healthcare costs and reforms. The 2026 survey included responses from 408 employers and purchasers, showcasing trends in how businesses perceive and respond to healthcare affordability challenges.

Why are employers becoming less alarmed about healthcare costs?

Employers may be experiencing a normalization effect, where high costs have become routine, leading to a reduced sense of urgency. Additionally, improvements in cost management strategies may contribute to this perception, as employers grow more adept at navigating the complexities of healthcare expenses.

What reforms are employers most supportive of?

Employers are showing strong support for various policy reforms, particularly in the areas of pharmacy benefit management, drug price regulation, and hospital price transparency. The significant increases in support across these categories reflect a desire for greater accountability and transparency in healthcare pricing.

How does the 340B Drug Pricing Program affect employers?

The 340B Drug Pricing Program, while intended to provide discounts for safety net hospitals, can inadvertently lead to higher costs for employer-sponsored health plans. This is due to the lack of rebates on drugs dispensed under the program, resulting in increased pharmacy costs for employers. As awareness of this issue grows, employer support for reforming the program has risen substantially.